Sophia Genetics SA (SOPH) — Financial Flexibility Index
Sophia Genetics SA (SOPH) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of $-8.69 Million (operating CF $-8.79 Million minus capex $106.00K) represents 0% of total liabilities ($102.77 Million). Check how strategically is Sophia Genetics SA's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sophia Genetics SA Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Sophia Genetics SA across 6 annual periods. See working capital to net assets of Sophia Genetics SA to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sophia Genetics SA (2019–2024)
Year-by-year free cash flow to debt coverage for Sophia Genetics SA. For the full company profile including market capitalisation, see SOPH market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.59x | $-34.65 Million | $-42.82 Million | $58.82 Million | ▲ +18.1% |
| 2023 | -0.72x | $-39.35 Million | $-48.58 Million | $54.71 Million | ▲ +47.4% |
| 2022 | -1.37x | $-59.71 Million | $-70.09 Million | $43.71 Million | ▼ -19.3% |
| 2021 | -1.15x | $-51.27 Million | $-57.94 Million | $44.77 Million | ▼ -26.9% |
| 2020 | -0.90x | $-28.53 Million | $-31.73 Million | $31.61 Million | ▲ +7.4% |
| 2019 | -0.97x | $-28.65 Million | $-31.68 Million | $29.40 Million | — |